Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
7.66
+0.42 (5.80%)
At close: Dec 26, 2024, 4:00 PM
7.65
-0.01 (-0.13%)
After-hours: Dec 26, 2024, 7:59 PM EST
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RXRX stock have an average target of 9.25, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 20.76% from the current stock price of 7.66.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RXRX stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 2 | 4 | 4 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 4 | 6 | 6 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +43.60% | Dec 11, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +43.60% | Nov 20, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +43.60% | Nov 7, 2024 |
Needham | Needham | Strong Buy Maintains $16 → $11 | Strong Buy | Maintains | $16 → $11 | +43.60% | Sep 4, 2024 |
Jefferies | Jefferies | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | -21.67% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
71.40M
from 44.58M
Increased by 60.17%
Revenue Next Year
85.59M
from 71.40M
Increased by 19.88%
EPS This Year
-1.62
from -1.58
EPS Next Year
-1.75
from -1.62
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 92.7M | 183.8M | 218.4M |
Avg | 71.4M | 85.6M | 128.4M |
Low | 44.1M | 45.1M | 73.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 108.0% | 157.4% | 155.2% |
Avg | 60.2% | 19.9% | 50.0% |
Low | -1.1% | -36.9% | -14.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.52 | -1.41 | -1.12 |
Avg | -1.62 | -1.75 | -1.46 |
Low | -1.86 | -2.84 | -1.76 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.